EO2 Concepts

What EO2 Concepts does

EO2 Concepts is a privately held medical device company founded in 2007 and headquartered in San Antonio, Texas, that develops wound care and monitoring systems designed to interface with advanced wound dressings. The company operates in a specialized niche of the chronic and acute wound care market, producing hardware-based therapy and monitoring products intended for clinical use in patient wound management. Specific product details, technical specifications, regulatory clearances (e.g., FDA 510(k) status), and clinical evidence are not disclosed in the available source material, and the company's website (eo2.com) returned only a loading page during data collection.

The company employs between 11 and 50 people and has been led by Mark Q. Niederauer as CEO and President, with Lee Kelley serving as CFO. EO2 Concepts has financed operations primarily through a long series of small equity or convertible rounds spanning 2009 through 2023, with cumulative disclosed funding of approximately $13.3M across 11 documented transactions. The largest single raises occurred in 2011 ($4.3M) and 2010 ($2.5M), while more recent rounds have ranged from $370K to $1M, suggesting the company is operating at a small, sustained scale rather than pursuing aggressive expansion.

The business model appears to follow a medical device commercialization path, with revenue likely generated through direct sales or distribution partnerships to hospitals, wound care clinics, and home health providers. However, no pricing, channel, or customer information was disclosed in the source data, and there is no public commentary on reimbursement strategy, sales coverage, or installed base. The combination of a narrow product focus, small headcount, and modest recent capital raises is consistent with a niche specialty medical device company maintaining a stable, limited footprint rather than a high-growth venture-backed business.

Name

EO2 Concepts

Website

https://eo2.com

Company type

Private

Founded year

2007

Operating status

Operating

Headcount range

11–50 employees

Short description

EO2 Concepts is a privately held San Antonio-based medical device company, founded in 2007, that develops wound care and monitoring systems for advanced wound dressings serving clinical wound management applications.

Ownership category

akta.pro rank

Product category

Wound Care Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Medical Equipment and Supplies Manufacturing (3391), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Advanced Wound Dressings (Foam, Hydrocolloid, Alginate, Hydrogel, Film) (HLAHALAA)

akta.pro secondary industries

Wound Care & Ulcer Management (HLAKACAN), Risk Stratification, Early Warning Scores & Predictive Analytics (HLACAGAE)

Keywords

• Wound care devices
• Wound monitoring systems
• Advanced wound dressings
• Medical device development
• Chronic wound therapy

Headquarters

HQ city

San Antonio

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales

Core offering

EO2 Concepts develops wound care and monitoring systems for advanced wound dressings. The company designs therapeutic and sensing hardware that clinicians use to treat and assess advanced wounds, integrating monitoring capability directly with the dressing system.

Differentiator

Problem solved

Functional benefit

Products and services

• Wound care and monitoring systems for advanced wound dressings

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves5 records

Expansion highlights1 record

Broad incumbents

• 3M Health Care / Solventum: Major advanced wound care player (Tegaderm, V.A.C. NPWT). Directly comparable to EO2 in wound dressings and NPWT categories, with a much broader medical-surgical franchise and global distribution.
• Smith & Nephew: Global medical device major with a large Advanced Wound Management portfolio (ALLEVYN, PICO NPWT). Comparable to EO2 as a leading supplier of advanced wound dressings and NPWT systems, though at vastly greater scale and broader portfolio breadth.
• Acelity (3M/KCI): KCI (now part of 3M/Solventum) is the dominant player in Negative Pressure Wound Therapy (V.A.C. therapy) and advanced dressings. Closest direct comparable to EO2's NPWT-adjacent wound care systems and consumables.
• Cardinal Health (Medical segment): Major medical products distributor with a wound care portfolio and large hospital supply footprint. Comparable to EO2 as a wound dressings supplier/distributor to US hospitals and IDNs, though at vastly broader scale.

Direct peers

• ConvaTec: Pure-play wound, ostomy and continence company with AQUACEL hydrofiber dressings and Avelle NPWT. Direct competitor to EO2 in advanced wound dressings, serving similar hospitals and home-care channels.
• Coloplast: Wound, ostomy and continence specialist with Biatain dressings. Comparable to EO2 as a chronic-wound dressings supplier serving hospitals, home care and long-term care facilities.
• Integra LifeSciences: Medtech company with a sizable Tissue Technologies / wound reconstruction portfolio (Integra dermal matrix, AmnioExcel). Comparable as a specialty wound care supplier addressing complex and chronic wounds in hospitals.
• Mölnlycke Health Care: Swedish wound care specialist (Mepilex, Mepitel, Avance NPWT). Highly comparable to EO2's advanced dressings/NPWT focus, with deep clinical-evidence base and European/US hospital presence.

Emerging players

• Organogenesis: US-listed regenerative medicine company (Apligraf, Dermagraft) focused on advanced wound healing. Comparable to EO2 in advanced/biological wound care for chronic wounds, though with a distinct cellular-product mechanism.
• MiMedx: US-listed wound care and surgical recovery company (EpiFix amniotic allografts). Comparable as an emerging specialty player selling advanced wound healing products into similar hospital and wound clinic channels as EO2.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights5 records

Customer concentration

• Xx.com/EO2Concepts
• Facebookfacebook.com/EO2Concepts
• LinkedInlinkedin.com/company/eo2-concepts

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds11 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about EO2 Concepts